Role of apoptosis in HIV disease pathogenesis

Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117–122, 1995 Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123–126 1995 Su L, Kanesima H, Bonyhadi M, Salimi S, Kraft D, Rabin L, McCune JM: HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity 2:25–36, 1995 Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruorecht RM, Kupfer A: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med 1:129–134, 1995 Lifson JD, Feinberg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Steimer KS, Engleman EB: Induction of CD4-dependent cell fusion by the HTLVIII/LAV envelope protein. Nature 323:725–728, 1986 Sodroski J, Goh WC, Rosen CA, Campbell K, Haseltine W: Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 322:470–474, 1986 Somasundaran M, Robinson HL: A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion. Nature 322:470–474, 1987 Kowalski M, Bergerson L, Dorfman T, Haseltine W, Sodorski J: Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope protein. J Virol 65:281–291, 1991 Bergeron L, Sodoroski J: Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1. J Virol 66:5777–5787, 1992 Cloyd MW, Lynn WS: Pertubation of host-cell membrane is a primary mechanism of HIV cytopathicity. Virology 181:307–309, 1991 Stevenson M, Meier C, Mann AM, Chapman N, Wasiak W: Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell 53:483–496, 1988 Koga Y, Nakamura K, Sasaki M, Kimura G, Nomoto K: The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing. Virology 201:137–141, 1992 DeRossi A, Franchini G, Aldovini A, DelMistro A, Chieco-Bianchi L, Gallo R, Wong-Staal F: Differential response to the cytopathic effects of human T-cell lymphotropic virus III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-1. Proc Natl Acad Sci USA 83:4297–4301, 1986 Terai C, Kornbluth RS, Pavia D, Richman DD, Carson DA: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87:1710–1715, 1991 Laurent-Crawford AG, Krust B, Muller S, Riviere Y, Rey-Culle M-A, Bechet JM, Montagnier L, Hovanessian AG: The cytopathic effect of HIV is associated with apoptosis. Virology 185:829–839, 1991 Laurent-Crawford AG, Krust B, Muller S, Riviere Y, Desgranges C, Muller S, Kieny MP, Daugust C, Hovanessian AG: Membrane expression of HIV envelope glycoprotein triggers apoptosis in CD4 cells. AIDS Res Human Retroviruses 9:761–773, 1993 Lu Y-Y, Koga Y, Tanaka K, Sasaki M, Kimura G, Nomoto K: Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1. J Virol 68:390–399, 1994 Su X, Zhou T, Wang Z, Yang P, Jope RS, Mountz JD: Defective expression of hematopoietic cell protein phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2:353–362, 1995 Pantaleo G, Graziosi C, Fauci AS: The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327–335, 1993 Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57:183–289, 1993 Zinkernagel RM, Hengartner H: T-cell-mediated immunopathology versus direct cytolysis: implication for HIV and AIDS. Immunol Today 15:262–268, 1994 Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide ranging implication in tissue kinetics. Br J Cancer 26:239–257, 1972 Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68:251–306, 1980 Ucker DS, Aswell JD, Nickas G: Activation-driven T cell death. I: Requirements for de novo transcription and translation and association of genome fragmentation. J Immunol 143:3461–3469, 1989 Asnwell JD, Cunningham RE, Noguchi PD, Hernandez D: J Exp Med 165:173–194, 1987 Woronicz JD, Calnan B, Hgo V, Winoto A: Requirement for orphan steroid receptor Nur77 in apoptosis of T-cell hybridoma. Nature 367:277–281, 1994 Liu Z-G, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA: Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur 77. Nature 367:281–284, 1994 Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR: Role for c-myc in activation-induced cell death in T cell hybridoma. Science 257:212–257, 1992 Bissonnette RP, McLaughin KA, Mahboubi A, Green DG: J Exp Med 180:2413–2418, 1994 Nagata S, Golstein P: The Fas death factor. Science 267:1449–1456, 1995 Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747–1756, 1989 Trauth BC, Klas C, Reters AMJ, Matzku S, Moller P, Falk W, Debatin K-M, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301–305, 1989 Ito N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata N: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233–243, 1991 Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169–1178, 1993 Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243–262, 1991 Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314–317, 1992 Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274–1279, 1992 Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969–976, 1994 Lynch DH, Watson ML, Alderson MR, Baum PR, Miller RE, Tough T, Gibson M, Davis-Smith T, Smith CA, Hunter K, Bhat D, Din W, Goodwin RG, Seldin MF: The mouse Fas-ligand gene is mutated in gld mice and is part of TNF family gene cluster. Immunity 1:131–136, 1994 Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mounz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759–1762, 1994 Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71–77, 1995 Dhein J, Walczac H, Baumler C, Debatin K-M, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438–441, 1995 Brunner T, Mogill R, LaFace D, Yoo NJ, Mahboul A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridoma. Nature 373: 441–444, 1995 Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444–448, 1995 Herron LR, Eisenberg RA, Roper E, Kakkanaiah VN, Cohen PPL, Kotzin BL: Selection of the T cell receptor repertoire in lpr mice. J Immunol 151:3450–3459, 1993 Musette P, Pannetier C, Gachelin G, Kourisky P: The expansion of a CD4+ T cell population bearing a distinctiveβ chain in MRL lpr/lpr mice suggests a role of the Fas protein in peripheral T cell selection. E J Immunol 24:2761–2766, 1994 Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic detection of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365–371, 1994 Russell J, Rush B, Weaver C, Wang R: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90:4409–4413, 1993 Bossu P, Singer GG, Andres P, Ettinger R, Marshak-Rothstein A, Abbas AK: Mature CD4+ T lymphocytes from MRL/lpr ice are resistant to receptor-mediated tolerance and apoptosis. J Immunol 151:7233–7239, 1994 Ju ST, Cui H, Panka D, Ettinger R, Marshak-Rothstein A: Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. Proc Natl Acad Sci USA 91:4185–4189, 1994 Heusel J, Wesselschmidt RL, Shresta S, Russel JH, Ley TJ: Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977–987, 1994 Käji D, Vignaux F, Lederman B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528–530, 1994 Kojima H, Someya-Shinohara Y, Takagaki Y, Ohno H, Saito T, Katayama T, Yagita H, Okumura K, Shinkai Y, Alt FW, Matsuzaki A, Yonehara S, Takayama H: Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357–364, 1994 Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigenmediated cell death. J Immunol 151:621–627, 1993 Nakayama K, Nakayama K-I, Negishi I, Kuida K, Sawa H, Loh DY: Target disruption of Bcl-2αβ in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 91:3700–3704, 1994 Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulation in human peripheral blood. J Immunol 149:3753–3758, 1992 Yoshino T, Kondo E, Cao L, Takahashi K, Hayashi K, Nomura S, Akagi T: Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 83:1856–1861, 1994 Veis DJ, Sentman CL, Bach EA, Korsmeyer SJ: Expression of Bcl-2 protein in murine and human thymocytes and peripheral T lymphocytes. J Immunol 151:2546–2554, 1993 Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, Bacon PA, Akbar AN: The progressive differentiation of primed T cells is associated with an increased susceptibility to apoptosis. E J Immunol 24:892–899, 1994 Gratiot-Deans J, Merino R, Nunez G, Turka LA: Bcl-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc Natl Acad Sci USA 91:10685–10689, 1994 Uehara T, Miyawaki T, Ohta K, Tamaru Y, Yokoi T, Nakamura S, Taniguchi A: Apoptotic cell death of primed CD45R0+ T lymphocytes in Epstein-Barr virus-induced infections mononucleosis. Blood 80:452–458, 1992 Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241–251, 1993 Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y: Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374:811–813, 1995 Jacobson MD, Raff MC: Programmed cell death and Bcl-2 protection in very low oxigen. Nature 374:814–816, 1995 Oltvai Z, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–619, 1993 Yin X-M, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321–323, 1994 Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597–608, 1993 Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimetric partner for Bcl-xL and Bcl-2, displaces Bax and promote cell death. Cell 80:285–291, 1995 Chittenden T, Harrington EA, O'Conner R, Flemington C, Lutz RJ, Evan GI, Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733–739, 1995 Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan J, Reed JC: Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell 80:279–284, 1995 Owen-Schaub LB, Yonehara S, Crump III WL, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cellular Immunol 140:197–295, 1992 Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH: Fas transduce activation signals in normal human T lymphocytes. J Exp Med 178:2231–2235, 1993 Itoh N, Nagata S: A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268: 10932–10937, 1993 Sato T, Irie S, Kitada S, Reed JC: FAP-1: A protein tyrosine phosphatase that associate with Fas. Science 268:411–415, 1995 Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D: Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. 2:341–351, 1995 Obeid LM, Linardic CM, Karolak LA, Hannun YA: Programmed cell death induced by ceramide. Science 259:1769–1771, 1993 Weigmann K, Schütze S, Machleidt T, Witte D, Krönke M: Functional dichotomy of neutral and acid sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005–1015, 1994 Van Veldhoven PP, Matthews TJ, Bolognasi DP, Bell RM: Change in bioactive lipids, alkyacylglycerol and ceramide, occur in HIV-infected cells. Biochem Biophys Res Commun 187:209–216, 1992 Rivas CI, Golde DW, Vera JC, Kolesnick RN: Involvement of the sphingomyelin pathway in autocrine tumor necrosis factor signaling for human immunodeficiency virus production in chronically infected HL-60 cells. Blood 83:2191–2197, 1994 Sarin A, Adams DH, Henkart PA: Protease inhibitors selectively block T-cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T-cells. J Exp Med 178:1693–1700, 1993 Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267: 2000–2003, 1995 Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78–81, 1995 Los M, de Craen MV, Penning LC, Schenk H, Westendorp M, Baeuerie PA, Dröge W, Krammer PH, Fiers W, Schulze-Osthoff K: Requirement of an ICE/CED-3 protease for Fas/Apo-1-mediated apoptosis. Nature 375:81–83, 1995 Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F: Programmed death of T cells in HIV-1 infection. Science 257:217–219, 1992 Groux H, Torpier G, Montè D, Mounton Y, Capon A, Ameisen JC: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency-infected asymptomatic individuals. J Exp Med 175:331–340, 1992 Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S: Accelerated apoptosis in peripheral blood mononuclear cells (PBMC) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392–3400, 1993 Carbonari M, Cibati M, Cherchi M, Sbarigia D, Pesce AM, Dell'Anna L, Modica A, Fiorilli M: Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 83:1268–1277, 1994 Sarin A, Clerici M, Blatt SP, Hendrix CW, Shearer GM, Henkart PA: Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. J Immunol 153:862–872, 1994 Meyaard L, Otto SA, Keet IPM, Roos MTL, Miedema F: Programmed death of T cells in human immunodeficiency virus infection. J Clin Invest 93:982–988, 1994 Lewis DE, Ng Tang DS, Adu-Oppong A, Schober W, Rodgers JR: Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol 153:412–420, 1994 Jaleco AC, Covas MJ, Victorino RMM: Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patients. Clin Exp Immunol 98:185–189, 1994 Schnittman SM, Psallidopoulos M, Lane HC,et al: The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305–308, 1992 Saksela K, Stevens C, Rubinstein P, Baltimore D: Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci USA 91:1104–1108, 1994 Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, Kaneshima H: HIV induces thymus depletion in vivo. Nature 363:728–732, 1993 Del Llano AM, Amerio-Puig JP, Kraiselburd EN, Kessler MJ, Malaga CA, Lavergne JA: The combined assessment of cellular apoptosi, mitochondrial function and proliferative response to pokeweed mitogen fas prognostic value in SIV infection. J Med Primatol 22:194–200, 1993 Bishop SA, Gruffydd-Jones TJ, Harbour DA, Stokes CR: PCD (apoptosis) as a mechanism of cell death in PBMC from cats infected with feline immunodeficiency virus (FIV). Clin Exp Immunol 93:65–71, 1993 Pahwa S, Pahwa R, Saxinger C, Gallo RC, Good RA: Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations. Proc Natl Acad Sci USA 82:8198–8202, 1985 Diamond DC, Sleckman BP, Gregory T, Lasky LA, Greenstein JL, Burakoff SJ: Inhibition of CD4+ T-cell function by the HIV envelope protein gp120. J Immunol 141:3715–3717, 1988 Chirmule N, Karyanarmann VS, Oyaizu N, Slade H, Pahwa S: Inhibition of functional properties of tetyanus antigen-specific T cell clones by envelope glycoproteins of HIV-1. Blood 75:152–159, 1990 Oyaizu N, Chirmule N, Kalyanaraman VS, Hall WW, Good RA, Pahwa S: Human immunodeficiency virus type 1 envelope protein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc Natl Acad Sci USA 87:2379–2383, 1990 Oyaizu N, Chirmule N, Pahwa S: Role of CD4 molecule in the induction of interleukin 2 and interleukin 2 receptor in class II major histocompatibility complex-restricted antigen specific T helper clones. J Clin Invest 89:1807–1816, 1992 Newell MK, Haughn LJ, Maroun CR, Julius MH: Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature 347:286–289, 1990 Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly R-P, Finkel TH: Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176:1099–1106, 1992 Oh S-K, Cruikshank WW, Raina J, Blanchard GC, Adler WH, Walker J, Kornfeld H: Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquired Immune Defic Syndr 5:251–256, 1992 Amadori A, Silvestro GD, Zamarchi R, Veronese ML, Mazza MR, Schiavo G, Panozzo M, DeRossi A, Ometto L, Mous J, Barelli A, Borri A, Salmaso L, Chieco-Bianchi L: CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients. J Immunol 148:2709–2716, 1992 Weimer R, Daniel V, Zimmermann R, Schimpf K, Opelz G: Autoantibodies against CD4 cells are associated with CD4 helper defects in human immunodeficiency virus-infected patients. Blood 77:133–140, 1991 Oyaizu N, McCloskey TW, Soe Than, Rong Hu, Kalyanaraman VS, Pahwa S: Crosslinking of CD4 Molecules Up-regulates Fas Antigen Expression in Lymphocytes by Inducing Interferonτ and Tumor Necrosis Factor-α Secretion. Blood 84:2622–2631, 1994 Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RT, Bloom BR: Differential lymphokine profile of functional subsets of human CD4 and CD8 T cell clone. Science 254:279–282, 1991 Swain S: Generation and in vivo persistence of polarized Th1 and Th2 memory cells. Immunity 1:543–552, 1994 Miyazaki T, Liu Z-J, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Perimutter RM, Taniguchi T: Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81: 223–231, 1995 Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadeen N, Pilling D, Pett S, Grundy JE, Janossy G: The significance of low bcl-2 expression by CD45R0 T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 178:427–438, 1993 Clerici M, Shearer GM: A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107–110, 1993 Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 91:759–765, 1993 Lahdevirta J, Maury CPJ, Teppo A-M, Repo H: Elevated levels of circulating cahectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85:289–291, 1988 Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, Martinez-Maza O: Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 144:480–484, 1990 Emille D, Permutter M, Malliot MC, Brousse N, Delfraissy JF, Dormont J, Galanaud P: Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest 86:148–159, 1990 Fan J, Bass HZ, Fahey JL: Elevated INF-τ and decreased IL-2 gene expression are associated with HIV infection. J Immunol 151:5031–5040, 1993 Graziosi C, Pantaleo G, Gantt KR, Fortin J-P, Demarrest JF, Cohen OJ, Sèkaly RP, Fauci AS: Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 265:248–252, 1994 Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, Farrar W: Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci USA 86:621–625, 1989 Clouse KA, Cosentino LM, Weih KA, Pyle SW, Robbins PB, Hochstein HD, Natarajan V, Farrar WL: The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 147:2892–2901, 1991 Oyaizu N, Chirmule N, Ohnishi Y, Kalyanaraman VS, Pahwa S: Human immunodeficiency virus type 1 envelope glycoprotein gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones. J Virol 65:6277–6282, 1991 Rieckmann P, Poli G, Fox CH, Kehrl JH, Fauci AS: Recombinant gp120 specifically enhances tumor necrosis factor-α production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. J Immunol 147:2922–2927, 1991 Soe Than, Oyaizu N, Kalyanaraman VS, Pahwa S: Effect of HIV-1 envelope protein gp160 on cytokine production from cord blood T cells. Blood 84:184–188, 1994 Gessani S, Puddu P, Varano B, Borghi P, Conti L, Fantuzzi L, Belardelli F: Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocyte macrophage. J Virol 68:1983–1986, 1994 Wang Z, Dudhane A, Orlikowsky T, Clarke K, Li X, Darzynkeiwicz Z, Hoffmann MK: CD4 engagement induces Fas antigen-dependent apoptosis in vivo. Eur J Immunol 24:1553–1557, 1994 Debatin K-M, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A, Krammer PH: High expression of Apo-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 83:3101–3103, 1994 McCloskey TW, Oyaizu N, Kaplan M, Pahwa S: Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry 22:111–114, 1995 Krowka JF, Sheppard HW, Acher MS, Fitzpatrick P, Kiefer MC, Pavioff N, Barr PJ: Soluble CD95 inhibits HIV-related apoptosis. Xth Int Conf AIDS, Yokohama 1994 (abstr #PA0105) Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 87:9620–9624, 1990 Zagury JF, Bernard J, Achour A, Astgen A, Lachgar A, Fall L, Carelli C, Issing W, Mbika JP, Picard O, Carlotti M, Callebaut I, Mornon JP, Burny A, Feldman M, Bizzini B, Zagury D: Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: Role in AIDS pathogenesis. Proc Natl Acad Sci USA 90:7573–7577, 1993 Szawlowski PWS, Hanke T, Randall RE: Sequence homology between HIV-1 gp120 and the apoptosis mediating protein Fas. AIDS 7:1018, 1993 (letter) Clement M-V, Stamenkovic I: Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions. J Exp Med 180:557–567, 1994 Wang J, Stolman SA, Dennert G: TCR cross-linking induces CTL death via internal action of TNF. J Immunol 152:3824–3832, 1994 Grell M, Zimmermann G, Hülser D, Pfizenmaier K, Scheurich P: TNF receptors TR60 and TR80 can mediate apoptosi via induction of distinct signal pathways. J Immunol 153:1963–1972 Liu Y, Janeway Jr CA: Interferonτ plays a critical role in induced cell death of effector T cell: A possible third mechanism of self-tolerance. J Exp Med 172:1735–1739m, 1990 Groux H, Monte D, Plouvier B, Capon A, Ameisen J-C: CD3-mediated apoptosis of human medullary thymocytes and activated T cells: respective roles of interleukin-1, interleukin-2, interferon-τ and accessory cells. E J Immunol 23:1623–1629, 1993 Novelli F, Pierro F, diCelle PF, Bertini S, Affaticati P, Garotta G, Forni G: Environmental signals influence expression of the IFN-τ receptor on human T cells control whether IFN-τ promotes proliferation or apoptosis. J Immunol 152:496–504, 1994 Leonardo MJ: Interleukin-2 programs mouseαβ T lymphocytes for apoptosis. Nature 363:858–861, 1991 Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt S, Hendrix CW, Wolf SF, Shearer GM, Henkart PA: Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad USA 91:11811–11815, 1995 Pope M, Betjes MGH, Romani N, Hirmand H, Cameron PU, Hoffman L, Gezelter S, Schuler G, Steinman RM: Conjugate of dendritic cells and memory T lymphocytes from skin facilitate productive infection of HIV-1. Cell 78:389–398, 1994 Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis C, Greenfield E, Barber M, Restivo, Jr VA, Ke X, Gray G, Nadler LK: CTLA4 mediates antigen-specific apoptosis of human T-cells. Proc Natl Sci USA 92:811–815, 1995 Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of Fas ligand in cells of T cell lineage. J Immunol 154:3806–3813, 1995 Wang Z, Orlikowsky T, Dudhane A, Clarke K, Li X, Darzynkeiwicz Z, Hoffmann MK: Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients. Eur J Immunol 24:1553–1557, 1994 Mosier DE, Gulizia RJ, Maclsaac PD, Torbett BE, Levy JA: Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science 260:689–692, 1993 Watanabe M, Ringler DJ, Fultz PN, MacKey JJ, Boyson JE, Levine CG, Letvin NL: A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease. J Virol 65:3344–3348, 1991 Johnson BK, Stone GA, Godec MS, Asher DM, Gajdusek DC, Gibbs Jr CJ: Long-term observations of human immunodeficiency virus-infected chimpanzees. AIDS Res Human Retroviruses 9:375–378, 1993 Gendelman HE, Ehrlich GD, Baca LM, Conley S, Ribas J, Kalter DC, Melzer MS, Poiez BJ, Nara P: The inability of human immunodeficiency virus to infect chimpanzee monocytes can be overcome by serial passage in vivo. J Virol 65:3853–3863, 1991 Schuitemaker H, Meyaard L, Kootstra NA, Dubbes R, Otto SA, Termette M, Heeney JL, Miedema F: Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. J Infec Dis 168:1140–1147, 1993 Hügin AW, Vacchio MS, Morse III HC: A virus-encoded “superantigen” in a retrovirus-induced immunodeficiency syndrome of mice. Science 252:424–427, 1991 Aziz DC, Hanna Z, Jolicoeur P: Sever immunodeficiency disease induced by a defective murine leukemia virus. Nature 338:505–508, 1989 van den Eterwegh AJM, Laman VD, Schellekens MM, Boersma WJA, Claassen E: Complement-mediated follicular localization of T-independent type-2 antigens: the role of marginal zone macrophage. Eur J Immunol 22:719–726, 1992 Clark EA, Ledbetter JA: How B and T cells talk to each other. Nature 367:425–428, 1994 Chakrabarti L, Isola P, Cumont M-C, Claessens-Maire M-A, Hurtrel M, Montagnier L, Hurtrel B: Early stages of simian immunodeficiency virus infection in lymph nodes. Am J Pathol 144:1226–1237, 1994 Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355–358, 1993 Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359–362, 1993 O'hara CJ: Lymphoid system.In Pathology and Pathophysiology of AIDS and HIV-Related Diseases. Chapman and Hall Medical 1989, pp 136–183 Cheynier R, Henrichwark S, Hadida F, Pelletier E, Oksenhendler E, Autran B, Wain-Hobson S: HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78:373–387, 1994 Bowen MB, Butch AW, Parvin CA, Levine A, Nahm MH: Germinal center T cells are distinct helper-inducer T cells. Human Immunol 31:67–76, 1991 Fuller KA, Kanagawa O, Nahm MH: T cells within germinal centers are specific for the immunizing antigen. J Immunol 151:4505–4512, 1993 Kearney ER, Pape KA, Loh DY, Jenkins MK: Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327–339, 1994 Joling P, Bakker LJ, Strijp JAG, Meerloo T, de Graaf L, Dekker MEM, Goudsmit J, Verhoef J, Schuurman H-J: Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent. J Immunol 150:1065–1073, 1993 Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson A: Tumor necrosis factor-alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kB sites in the long terminal repeat. Proc Natl Acad Sci USA 86:5974–5978, 1989 Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, Fauci AS: Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factorα by transcriptional and post-transcriptional mechanisms. J Exp Med 172:151–158, 1990 Biswas P, Poli G, Kinter AL, Justment JS, Stanley SK, Maury WJ, Bressler P, Orenstein JM, Fauci AS: Interferon-gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J Exp Med 176:739–750, 1992 Biswas P, Poli G, Orenstein JM, Fauci AS: Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: Do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? J Virol 68:2598–2604, 1994